SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
(Photo: adapted from Charles Williams/flickr)
As many as 2,600 "human guinea pigs" died in the past seven years during drug trials by foreign pharmaceutical corporations, The Times of India reports on Thursday.
Trials for two drugs by pharma giants Bayer and Novartis "accounted for maximum number of deaths," they report.
"Serious adverse events of deaths during the clinical trials during the said period were 2,644, out of which 80 deaths were found to be attributable to the clinical trials," health secretary Keshav Desiraju said in an affidavit on behalf of the ministry of health and family welfare.
"Around 11,972 serious adverse events (excluding death) were reported during the period from January 1, 2005 to June 30, 2012, out of which 506 events were found to be related to clinical trials," he added.
According to the paper, trials of 475 drugs took place but only 17 of them were approved for marketing in India.
__________________________
Trump and Musk are on an unconstitutional rampage, aiming for virtually every corner of the federal government. These two right-wing billionaires are targeting nurses, scientists, teachers, daycare providers, judges, veterans, air traffic controllers, and nuclear safety inspectors. No one is safe. The food stamps program, Social Security, Medicare, and Medicaid are next. It’s an unprecedented disaster and a five-alarm fire, but there will be a reckoning. The people did not vote for this. The American people do not want this dystopian hellscape that hides behind claims of “efficiency.” Still, in reality, it is all a giveaway to corporate interests and the libertarian dreams of far-right oligarchs like Musk. Common Dreams is playing a vital role by reporting day and night on this orgy of corruption and greed, as well as what everyday people can do to organize and fight back. As a people-powered nonprofit news outlet, we cover issues the corporate media never will, but we can only continue with our readers’ support. |
As many as 2,600 "human guinea pigs" died in the past seven years during drug trials by foreign pharmaceutical corporations, The Times of India reports on Thursday.
Trials for two drugs by pharma giants Bayer and Novartis "accounted for maximum number of deaths," they report.
"Serious adverse events of deaths during the clinical trials during the said period were 2,644, out of which 80 deaths were found to be attributable to the clinical trials," health secretary Keshav Desiraju said in an affidavit on behalf of the ministry of health and family welfare.
"Around 11,972 serious adverse events (excluding death) were reported during the period from January 1, 2005 to June 30, 2012, out of which 506 events were found to be related to clinical trials," he added.
According to the paper, trials of 475 drugs took place but only 17 of them were approved for marketing in India.
__________________________
As many as 2,600 "human guinea pigs" died in the past seven years during drug trials by foreign pharmaceutical corporations, The Times of India reports on Thursday.
Trials for two drugs by pharma giants Bayer and Novartis "accounted for maximum number of deaths," they report.
"Serious adverse events of deaths during the clinical trials during the said period were 2,644, out of which 80 deaths were found to be attributable to the clinical trials," health secretary Keshav Desiraju said in an affidavit on behalf of the ministry of health and family welfare.
"Around 11,972 serious adverse events (excluding death) were reported during the period from January 1, 2005 to June 30, 2012, out of which 506 events were found to be related to clinical trials," he added.
According to the paper, trials of 475 drugs took place but only 17 of them were approved for marketing in India.
__________________________